Activation of Dendritic Cells Via Inhibition of Jak2/STAT3 Signaling

Overview

Journal J Immunol

Specialty Allergy & Immunology

Date 2005 Sep 24

PMID 16177074

Citations 81

Authors

Yulia Nefedova

Pingyan Cheng

Daniele Gilkes

Michelle Blaskovich

Amer A Beg

Said M Sebti

Dmitry I Gabrilovich

Affiliations

Soon will be listed here.

Abstract

Signaling via Jak2/STAT3 is critically important for normal dendritic cell (DC) differentiation. In addition, we have previously demonstrated that hyperactivation of the Jak2/STAT3 pathway induced by tumor-derived factors (TDF) may be responsible for abnormal DC differentiation in cancer. In this study, using a novel selective inhibitor of Jak2/STAT3, JSI-124, we investigated the mechanism of the Jak2/STAT3 effect on DCs and the possibility of pharmacological regulation of DC differentiation in cancer. Our experiments have demonstrated that JSI-124 overcomes the differentiation block induced by TDF and promotes the differentiation of mature DCs and macrophages. Surprisingly, inhibition of Jak2/STAT3 signaling resulted in dramatic activation of immature DCs generated in the presence of TDF as well as in control medium. This activation manifested in up-regulation of MHC class II, costimulatory molecules, and a dramatic increase in the ability to stimulate allogeneic or Ag-specific T cells. Inhibition of Jak2/STAT3 signaling resulted in activation of the transcription factor NF-kappaB. This up-regulation was not due to a conventional pathway involving IkappaB alpha, but was probably due to a block of the dominant negative effect of STAT3. This indicates that Jak2/STAT3 play an important role in negative regulation of DC activation, and pharmacological inhibition of the Jak2/STAT3 pathway can be used to enhance DC function.

Citing Articles

Identification of signaling networks associated with lactate modulation of macrophages and dendritic cells.

Sangsuwan R, Thuamsang B, Pacifici N, Tachachartvanich P, Murphy D, Ram A Heliyon. 2025; 11(3):e42098.

PMID: 39975831 PMC: 11835580. DOI: 10.1016/j.heliyon.2025.e42098.

Electroporation-mediated novel albumin-fused Flt3L DNA delivery promotes cDC1-associated anticancer immunity.

Hu M, Fan D, Tu H, Tsai Y, He L, Zhou Z Gene Ther. 2024; .

PMID: 39472678 DOI: 10.1038/s41434-024-00497-3.

Tumor-associated macrophages, dendritic cells, and neutrophils: biological roles, crosstalk, and therapeutic relevance.

Shen M, Du Y, Ye Y Med Rev (2021). 2023; 1(2):222-243.

PMID: 37724296 PMC: 10388790. DOI: 10.1515/mr-2021-0014.

Signaling pathways involved in the biological functions of dendritic cells and their implications for disease treatment.

Cheng H, Chen W, Lin Y, Zhang J, Song X, Zhang D Mol Biomed. 2023; 4(1):15.

PMID: 37183207 PMC: 10183318. DOI: 10.1186/s43556-023-00125-3.

Defective Induction of IL-27-Mediated Immunoregulation by Myeloid DCs in Multiple Sclerosis.

von Glehn F, Pochet N, Thapa B, Raheja R, Mazzola M, Jangi S Int J Mol Sci. 2023; 24(9).

PMID: 37175706 PMC: 10179146. DOI: 10.3390/ijms24098000.

References

Liou H, Baltimore D . Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system. Curr Opin Cell Biol. 1993; 5(3):477-87. DOI: 10.1016/0955-0674(93)90014-h. View

Gabrilovich D, Chen H, Girgis K, Cunningham H, Meny G, Nadaf S . Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med. 1996; 2(10):1096-103. DOI: 10.1038/nm1096-1096. View

Pierre P, Turley S, Gatti E, Hull M, Meltzer J, Mirza A . Developmental regulation of MHC class II transport in mouse dendritic cells. Nature. 1997; 388(6644):787-92. DOI: 10.1038/42039. View

Gabrilovich D . Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol. 2004; 4(12):941-52. DOI: 10.1038/nri1498. View

Hoentjen F, Sartor R, Ozaki M, Jobin C . STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells. Blood. 2004; 105(2):689-96. DOI: 10.1182/blood-2004-04-1309. View

Turley S, Inaba K, GARRETT W, Ebersold M, Unternaehrer J, Steinman R . Transport of peptide-MHC class II complexes in developing dendritic cells. Science. 2000; 288(5465):522-7. DOI: 10.1126/science.288.5465.522. View

Imada K, Leonard W . The Jak-STAT pathway. Mol Immunol. 2000; 37(1-2):1-11. DOI: 10.1016/s0161-5890(00)00018-3. View

Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu Y . Immunobiology of dendritic cells. Annu Rev Immunol. 2000; 18:767-811. DOI: 10.1146/annurev.immunol.18.1.767. View

Rane S, Reddy E . Janus kinases: components of multiple signaling pathways. Oncogene. 2000; 19(49):5662-79. DOI: 10.1038/sj.onc.1203925. View

10.

Reith W, MACH B . The bare lymphocyte syndrome and the regulation of MHC expression. Annu Rev Immunol. 2001; 19:331-73. DOI: 10.1146/annurev.immunol.19.1.331. View

11.

Lanzavecchia A, Sallusto F . Regulation of T cell immunity by dendritic cells. Cell. 2001; 106(3):263-6. DOI: 10.1016/s0092-8674(01)00455-x. View

12.

Cheng P, Zlobin A, Volgina V, Gottipati S, Osborne B, Simel E . Notch-1 regulates NF-kappaB activity in hemopoietic progenitor cells. J Immunol. 2001; 167(8):4458-67. DOI: 10.4049/jimmunol.167.8.4458. View

13.

Ouaaz F, Arron J, Zheng Y, Choi Y, Beg A . Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity. 2002; 16(2):257-70. DOI: 10.1016/s1074-7613(02)00272-8. View

14.

Yu Z, Zhang W, Kone B . Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB. Biochem J. 2002; 367(Pt 1):97-105. PMC: 1222853. DOI: 10.1042/BJ20020588. View

15.

Welte T, Zhang S, Wang T, Zhang Z, Hesslein D, Yin Z . STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc Natl Acad Sci U S A. 2003; 100(4):1879-84. PMC: 149927. DOI: 10.1073/pnas.0237137100. View

16.

Blaskovich M, Sun J, Cantor A, Turkson J, Jove R, Sebti S . Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res. 2003; 63(6):1270-9. View

17.

Kusmartsev S, Cheng F, Yu B, Nefedova Y, Sotomayor E, Lush R . All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. Cancer Res. 2003; 63(15):4441-9. View

18.

Steinman R . Some interfaces of dendritic cell biology. APMIS. 2003; 111(7-8):675-97. DOI: 10.1034/j.1600-0463.2003.11107802.x. View

19.

Cheng F, Wang H, Cuenca A, Huang M, Ghansah T, Brayer J . A critical role for Stat3 signaling in immune tolerance. Immunity. 2003; 19(3):425-36. DOI: 10.1016/s1074-7613(03)00232-2. View

20.

Laouar Y, Welte T, Fu X, Flavell R . STAT3 is required for Flt3L-dependent dendritic cell differentiation. Immunity. 2003; 19(6):903-12. DOI: 10.1016/s1074-7613(03)00332-7. View